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Ex-ante socio-economic research is considered a crucial factor to successfully introduce novel, controversial 
goods, such as GM foods. This research compiles different studies that investigate ex-ante the potential of 
folate biofortified rice (FBR). From a policy point of view, economic evaluation is needed to assess whether 
FBR as a potential health intervention is worthwhile to undertake, while knowledge of its demand is needed 
to evaluate the market potential of FBR as a controversial GM food crop. Therefore, emphasis is put on three 
different lines of inquiry, i.e. acceptance, willingness-to-pay (WTP) and cost-effectiveness, which can be 
categorized based on the level of analysis, micro versus macro. While the former two are examined at the 
individual consumer level (micro), the macro-level looks at the potential cost-effectiveness for a society as 
a whole (macro). Also the research location differs according to this level: at micro-level, the consumer 
studies are conducted in a high-risk region, Shanxi Province, while at macro-level FBR is evaluated from the 
point of view of the broad society, i.e. China and its regions. 
Both micro-level studies lend support for a substantial market for FBR in target regions. Shanxi consumers 
generally accept FBR (62 %) and are even prepared to pay 34 % more than for regular rice. The health 
impact study further supports FBR as a valuable micronutrient strategy. When implemented in China, FBR 
could reduce 20 to 60 % of the burden of folate deficiency. Moreover, as it would cost between US$ 21.4 and 
US$ 64.2 to save a DALY, FBR is considered a highly cost-effective health intervention.  
Despite its potential, both at micro and macro level, biofortification alone will not be sufficient to completely 
eradicate the folate burden. 
 
Scientific abstract (1785 characters) 
Question:  
Ex-ante socio-economic research is considered a crucial factor to successfully introduce novel, controversial 
goods, such as GM foods. This research compiles different studies that investigate ex-ante the potential of 
folate biofortified rice (FBR). From a policy point of view, an economic evaluation is crucial to assess 
whether FBR as a potential health intervention is worthwhile to undertake, while knowledge of its demand 
is needed to evaluate the market potential of FBR as a controversial GM food crop. Therefore, emphasis is 
put on three different lines of inquiry, i.e. acceptance, willingness-to-pay (WTP) and cost-effectiveness. 
While the former two are examined at the individual consumer level (micro), the macro-level looks at the 
potential cost-effectiveness for a society as a whole (macro).  
Methods:  
At micro-level, the consumer studies (standardized survey, experimental auctions) are conducted in a high-
risk region, i.e. Shanxi Province, while at macro-level FBR is evaluated from the point of view of the broad 
society, i.e. China and its regions, through the application of the DALY approach to cost-effectiveness 
analysis 
Results and conclusions:  
Both micro-level studies lend support for a substantial market for FBR in target regions. Shanxi consumers 
generally accept FBR (62 %) and are even prepared to pay 34 % more than for regular rice. The health 
impact study further supports FBR as a valuable micronutrient strategy. When implemented in China, FBR 
could reduce 20 to 60 % of the burden of folate deficiency. Moreover, as it would cost between US$ 21.4 and 
US$ 64.2 to save a DALY, FBR is considered a highly cost-effective health intervention.  
Despite its potential, both at micro and macro level, biofortification alone will not be sufficient to completely 
eradicate the folate burden. 
 
